Pesicka Edward A's Form 4 filing
Accendra Health Inc (ACH) · filed Aug 13, 2021
- Accession no.
- 0000075252-21-000139
- Filed
- Aug 13, 2021
- Trade date
- Aug 11, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $1.23M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pesicka Edward ACIK 0001439487 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Weighted average of the sale price range of $38.10 through $39.09.
Referenced by the price of 1 transaction in Table I.
- F3
Weighted average of the sale price range of $38.08 through $39.06.
Referenced by the price of 1 transaction in Table I.